Skip to content
PICO Portalanswers from OpenAlex

Anti–microRNA-21 oligonucleotides prevent Alport nephropathy progression by stimulating metabolic pathways

PaperCitations, authors & open-access status

Anti–microRNA-21 oligonucleotides prevent Alport nephropathy progression by stimulating metabolic pathways is a paper indexed in PICO Portal from OpenAlex.

How many citations does Anti–microRNA-21 oligonucleotides prevent Alport nephropathy progression by stimulating metabolic pathways have?

PICO Portalcitation count

Anti–microRNA-21 oligonucleotides prevent Alport nephropathy progression by stimulating metabolic pathways has 409 citations in the OpenAlex counts PICO Portal stores.

When was Anti–microRNA-21 oligonucleotides prevent Alport nephropathy progression by stimulating metabolic pathways published?

PICO Portalyear

Anti–microRNA-21 oligonucleotides prevent Alport nephropathy progression by stimulating metabolic pathways has 2014 year in the PICO Portal index.

What is the open-access status of Anti–microRNA-21 oligonucleotides prevent Alport nephropathy progression by stimulating metabolic pathways?

PICO Portaloa status

Anti–microRNA-21 oligonucleotides prevent Alport nephropathy progression by stimulating metabolic pathways has bronze oa status in the PICO Portal index.

What is the DOI of Anti–microRNA-21 oligonucleotides prevent Alport nephropathy progression by stimulating metabolic pathways?

PICO Portaldoi

The DOI for Anti–microRNA-21 oligonucleotides prevent Alport nephropathy progression by stimulating metabolic pathways is on the source record.

What is the PMID of Anti–microRNA-21 oligonucleotides prevent Alport nephropathy progression by stimulating metabolic pathways?

PICO Portalpmid

The PMID for Anti–microRNA-21 oligonucleotides prevent Alport nephropathy progression by stimulating metabolic pathways is on the source record.

What is the OpenAlex record for Anti–microRNA-21 oligonucleotides prevent Alport nephropathy progression by stimulating metabolic pathways?

PICO Portalopenalex

The OpenAlex for Anti–microRNA-21 oligonucleotides prevent Alport nephropathy progression by stimulating metabolic pathways is on the source record.

Related on PICO Portal

470M+ articles · 14-day free trial